Skip to main content

Table 4 The effects of classical prognostic factors on DFS, OS and EFS

From: Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy

Characteristics

DFS (months)

OS (months)

EFS (months)

Median (95% CI)

Log-rank test

Median (95% CI)

Log-rank test

Median (95% CI)

Log-rank test

Tumor size

  ≤ 20 mm

NR

NR

ns

NR

 

  > 20 - ≤ 30 mm

NR

0.0082

NR

 

71 (> 71)

0.013

  > 30 mm

70 (> 38)

 

NR

 

70 (> 38)

 

Tumor grade

 Grade 1

NR

ns

NR

ns

NR

ns

 Grade 2/3

NR

 

NR

 

NR

 

Estrogen receptor

  ≥ 50%

NR

ns

NR

ns

NR

ns

  < 50%

NR

70 (> 70)

70 (> 70)

Ki67 index

  < 15%

NR

ns

NR

ns

NR

ns

  ≥ 15%

NR

NR

NR

uPA and PAI-1 levels

 Both elevated

NR (> 70)

 

NR

 

NR (> 70)

ns

 One elevated

NR

ns

NR

ns

NR

 Both normal

NR (> 71)

 

NR

 

NR (> 71)

  1. NR-not reached; ns-not statistically significant